Details about Mogibacterium: NCBI 86331

gram-negative or unknown

Other Names: Mogibacterium Mogibacterium Nakazawa et al. 2000

Change Display Name to


Distribution Chart and Statistics    |    End Products Produced   |    📚 PubMed Citations

Recommended reading: Taxonomy Nightmare

Does a specific lab/source detect it?


Click on to see lab specific distribution
SourcePercentagesamples
es-xenogene 25 % 4
SequentiaBiotech 2.56 % 39
CosmosId 0 % 15
AmericanGut 66.67 % 18
custom 0 % 3
Microba 0 % 5
Medivere 100 % 2
uBiome 61.52 % 832
Thryve 70.53 % 587
BiomeSight 82.58 % 419

Desired Levels from Some Experts

Percentage Seen in Sample
Low Boundary High Boundary Source
0.0012 %0.418 % Kaltoft-Moltrup Normal Ranges

Ranges can vary from lab to lab because of different equipment and software being used.

Possible Health Impacts

I would like to know about this bacteria's

🔐 From Citizen Science 2.0

Citizen Science 2.0 Explorer. List is restricted to associations with a high count and a change of random occurance greater than 1 in 100.

Only the 10 most significant associations are shown
SymptomsRangeOdds
General: Fatigue      Between 50%ile to 100%ile    1 to 4951.5
Neurological: Impairment of concentration      Between 50%ile to 100%ile    1 to 1455.4
Comorbid: Multiple Chemical Sensitivity      Between 66%ile to 100%ile    1 to 867.3
Neuroendocrine Manifestations: Dry Eye (Sicca or Sjogren Syndrome)      Between 50%ile to 100%ile    1 to 866.5
Neuroendocrine Manifestations: worsening of symptoms with stress.      Between 50%ile to 100%ile    1 to 834.2
Sleep: Unrefreshed sleep      Between 50%ile to 100%ile    1 to 597.9
Neurocognitive: Absent-mindedness or forgetfulness      Between 50%ile to 100%ile    1 to 567.8
Neurocognitive: Slowness of thought      Between 50%ile to 100%ile    1 to 463.8
Neuroendocrine Manifestations: recurrent feelings of feverishness      Between 50%ile to 100%ile    1 to 441.8

From Published Science

Based on Studies on PubMed
Medical ConditionDirectionPValue
Atherosclerosis High 📚 1 citations
Colorectal Cancer High 📚 1 citations
Liver Cirrhosis High 📚 1 citations
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic Low 📚 1 citations
Schizophrenia High 📚 1 citations
Ankylosing spondylitis High 📚 1 citations
Alzheimer's disease Low 📚 1 citations

I would like to know what can change the quality that I have

You can compare microbiome impact of these by checking the desired items (try keeping the numbers below six(6) and clicking

📓 - direct citation | 👪 - Impacts Parent Taxa | 👶 - Impacts Child Taxa | 🧙 - Inferred
Search Hints: Spice | Herb | Vitamin | Probiotics | Diet | Food | Amino |Flavonoids
General Substance Specific Substance Effect
butyrate supplements sodium butyrate 📓 📚 Decreases from 1 studies
Diet Style dietary fiber 👪 📚 Increases from 1 studies
Diet Style high fiber diet 👪 📚 Increases from 1 studies
Diet Style low protein diet 📓 📚 Increases from 2 studies
dietary fiber Psyllium (Plantago Ovata Husk) 📓 📚 Decreases from 1 studies
high fiber diet dietary fiber 👪 📚 Increases from 1 studies
high fiber diet high fiber diet 👪 📚 Increases from 1 studies
low/no meat diet low protein diet 📓 📚 Increases from 2 studies
Miscellaneous, food additives, and other odd items sodium butyrate 📓 📚 Decreases from 1 studies
Prebiotics and similar resistant starch 👪 📚 Increases from 1 studies
resistant starch resistant starch 👪 📚 Increases from 1 studies

A P-value below 0.0001 is the recommended threshold. A larger R-Square value means a stronger relationship. This is unpublished data using Properitary Artificial Intelligence.

🔐 Details about Mogibacterium: Bacteria Interplay


(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.